This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Feb 18;379(9816):598-9.

doi: 10.1016/S0140-6736(11)61614-0. Epub 2012 Jan 4.

Herpes simplex virus: a new era?

Philippe Van de Perre¹, Nicolas Nagot

Affiliations

PMID: 22226046
DOI: 10.1016/S0140-6736(11)61614-0

Comment

Herpes simplex virus: a new era?

Philippe Van de Perre et al. Lancet. 2012.

. 2012 Feb 18;379(9816):598-9.

doi: 10.1016/S0140-6736(11)61614-0. Epub 2012 Jan 4.

Authors

Philippe Van de Perre¹, Nicolas Nagot

Affiliation

¹ INSERM U 1058, Montpellier, France. p-van_de_perre@chu-montpellier.fr

PMID: 22226046
DOI: 10.1016/S0140-6736(11)61614-0

No abstract available

PubMed Disclaimer

Comment on

Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials.
Johnston C, Saracino M, Kuntz S, Magaret A, Selke S, Huang ML, Schiffer JT, Koelle DM, Corey L, Wald A. Johnston C, et al. Lancet. 2012 Feb 18;379(9816):641-7. doi: 10.1016/S0140-6736(11)61750-9. Epub 2012 Jan 4. Lancet. 2012. PMID: 22225814 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information